Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study compares the efficacy of risperidone and olanzapine to that of first-generation antipsychotics (FGAs) in patients with schizophrenia, who failed to show a response to initial trials of FGAs.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Pharmacopsychiatry

Title: Pharmacopsychiatry

Publisher: Georg Thieme Verlag KG

ISSN (Electronic): 1439-0795

ISSN (Print): 0176-3679

Publication date (Electronic): Mar 2012

Volume: 45

Issue: 2

Affiliations

[1 ] Department of General Psychiatry, Taoyuan Mental Hospital, Taoyuan, Taiwan.

Article

DOI: 10.1055/s-0031-1291293

PubMed ID: 22086749

SO-VID: 8fe55dee-78ed-4e93-90da-9e816d61b101

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 3

See all cited by